We are delighted to announce another step in our growth strategy, – ALS has completed the acquisition of Mikrolab Group on 3rd October 2017.
The group included Mikrolab Stockholm AB, MKL Diagnostics AB and Toxicon AB. Mikrolab and Toxicon provide a full range of services to the Pharmaceutical, Food and Environmental markets.
The acquisition brings new capabilities to ALS allowing us to offer additional services to our clients and expand our presence as a significant Global Pharmaceutical testing business and as a leading analytical testing service provider with extensive capabilities and geographical coverage. ALS will also be able to offer the full network of services to the Mikrolab and Toxicon client base.
The acquired assets include two sites located in Stockholm and Landskrona in Sweden and bring 30 staff to the ALS Family.
We warmly welcome the Mikrolab team!
Enquiries: Andreas Jonsson, Matthew Masters.